Clinical Trial Update: Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is recruiting to evaluate the role of citicoline in treating neonates with hypoxic-ischemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Armed Forces Hospital, Pakistan | Conditions: Hypoxic Ischemic Encephalopathy of Newborn | Phase 1 | Status: RECRUITING